Reduce lower extremity muscle stiffness
- Trial ID
- NCT05884944
- Official Title
- Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients
- Goal
- Reduce lower extremity muscle stiffness
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- New York Institute of Technology
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson Disease, Osteopathy in Diseases Classified Elsewhere
- Interventions
- Sham- Light touch, not reaching restrictive barrier, Experimental: Interventional Group- OMM- Muscle energy
Plain-Language Summary
Aiming to see if osteopathic manipulative medicine, specifically muscle energy techniques, can reduce lower‑extremity muscle stiffness and improve leg pain, cramping, or gait problems in people with Parkinson's. The treatment asks patients to make gentle, active muscle contractions against the practitioner's resistance to relax and lengthen tight muscles, and outcomes are measured with a MyotonPRO device and gait tests; it is compared to a sham light touch that avoids the restrictive barrier, and as a hands‑on therapy it does not directly change medications like levodopa. Seeking adults 18 and older with a neurologist diagnosis of Parkinson's at Hoehn and Yahr stage 2 to 4 who can lie supine and prone for measurements, walk for gait testing, and have PD‑related leg symptoms. People with other neurologic conditions affecting tone or walking, non‑PD gait disorders, or severe muscle fasciculations are excluded.
Locations
- NYIT College of Osteopathic Medicine, Old Westbury, New York, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Sham- Light touch, not reaching restrictive barrier. Aiming to see if osteopathic manipulative medicine, specifically muscle energy techniques, can reduce lower‑extremity muscle stiffness and improve leg pain, cramping, or gait problems in people with Parkinson's. The treatment asks patients to make gentle, active muscle contractions against the practitioner's resistance to relax and lengthen tight muscles, and outcomes are measured with a MyotonPRO device and gait tests; it is compared to a sham light touch that avoids the restrictive barrier, and as a hands‑on therapy it does not directly change medications like levodopa. Seeking adults 18 and older with a neurologist diagnosis of Parkinson's at Hoehn and Yahr stage 2 to 4 who can lie supine and prone for measurements, walk for gait testing, and have PD‑related leg symptoms. People with other neurologic conditions affecting tone or walking, non‑PD gait disorders, or severe muscle fasciculations are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 5 months.